EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prevalence and correlates of daily cannabis use in Great Britain in 2023–2024: Results from a nationally representative cross‐sectional survey

Hannah Walsh, Eve Taylor, Leonie Brose, Laura Bunce, Hazel Cheeseman, Elle Wadsworth

Addiction · 2026-11-09

DOI: 10.1111/add.70614 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background and aims Cannabis health harms increase as use increases, but little is known about who is more likely to use frequently. In England and Wales in 2025, it was estimated that 470 000 adults used cannabis daily. We aimed to provide an estimate for Great Britain, and to examine associations between daily use and socio‐demographic characteristics, mental health and nicotine use variables. Design Pooled data from repeat cross‐sectional national online surveys (Action on Smoking and Health) fielded in February–March 2023 and 2024. Setting Great Britain. Participants Adults aged ≥18 years ( n = 25 537). Measurements Self‐reported past‐year and daily cannabis use prevalence. Correlates of daily use were assessed using stepwise quasi‐Poisson regression models. Results Prevalence of past‐year cannabis consumption was 7.2% ( n = 1882) and, of these, 24.2% ( n = 432) reported daily cannabis use. Factors associated with increased risk of daily cannabis use included being older than 24 [25–35 years adjusted risk ratio (aRR) = 1.60, 95% confidence interval (CI) = 1.16–2.21; 35–44 years aRR = 2.09, 95% CI = 1.53–2.84; 45–54 years aRR = 2.03, 95% CI = 1.46–2.83; 55 + years aRR = 1.76, 95% CI = 1.23–2.53]; being unemployed (aRR = 1.34, 95% CI = 1.12–1.61); currently smoking tobacco (aRR = 1.82, 95% CI = 1.51–2.18) and using a combustible route of cannabis administration (aRR = 1.62, 95% CI = 1.26–2.08). Gender, ethnicity, region, social grade, anxiety or depression were not associated with daily use. Summary In Great Britain, 1.2 million people are estimated to be using cannabis daily. Daily cannabis use is more common among people who are older, are less advantaged and smoke tobacco.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →